From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles

Michael D. Delost, David T. Smith, Benton J. Anderson, Jon T. Njardarson

Research output: Contribution to journalReview articlepeer-review

98 Scopus citations

Fingerprint

Dive into the research topics of 'From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds